Neodynamics
0,95 SEK +0,21%HC Andersen Capital modtager betaling fra Neodynamics for en Digital IR/Corporate Visibility abonnementsaftale. Læs mere her.
7 investorer følger denne virksomhed
NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden.
Omsætning
320 t
EBIT %
-28.425 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
NEOD
Daglig lav / høj pris
0,888 / 0,95
SEK
Markedsværdi
30,98 mio. SEK
Aktieomsætning
4,76 t SEK
Volumen
5,3 t
Analyst
Claus Thestrup
CEO, Sweden
Seneste videoer
Finanskalender
Delårsrapport
07.05.2024
Generalforsamling
22.05.2024
Delårsrapport
20.08.2024
Delårsrapport
19.11.2024
Årsrapport
17.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Gryningskust Holding AB | 32,9 % | 32,9 % |
Rentability Sweden AB | 4,0 % | 4,0 % |
Premium
This content is for our Premium customers only.
Forum opdateringer
ViserAlle indholdstyper
Update on NeoDynamics’ Management Team
NeoDynamics announces outcome of RIghts issue of shares
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools